Zixuan Mei

Zixuan Mei

Auto-generated profile, based on publicly available information

Zixuan Mei

Department of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZMZixuan Mei
Zixuan Mei
KYKamuran Yilamu
Kamuran Yilamu
WNWeiyu Ni
Weiyu Ni
PSPanyang Shen
Panyang Shen
NPNan Pan
Nan Pan
SSShuying Shen
Shuying Shen
Osteoarthritis is the most prevalent age-related degenerative joint disease and is closely linked to obesity. However, the underlying mechanisms remain unclear. Here we show that altered lipid metabolism in chondrocytes, particularly enhanced fatty acid oxidation (FAO), contributes to osteoarthritis progression. Excessive FAO causes acetyl-CoA accumulation, thereby altering protein-acetylation profiles, where the core FAO enzyme HADHA is hyperacetylated and activated, reciprocally boosting FAO activity and exacerbating OA progression. Mechanistically, elevated FAO reduces AMPK activity, impairs SOX9 phosphorylation, and ultimately promotes its ubiquitination-mediated degradation. Additionally, acetyl-CoA orchestrates epigenetic modulation, affecting multiple cellular processes critical for osteoarthritis pathogenesis, including the transcriptional activation of MMP13 and ADAMTS7. Cartilage-targeted delivery of trimetazidine, an FAO inhibitor and AMPK activator, demonstrates superior efficacy in a mouse model of metabolism-associated post-traumatic osteoarthritis. These findings suggest that targeting chondrocyte-lipid metabolism may offer new therapeutic strategies for osteoarthritis.

10 April 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
WNWeiyu Ni
Weiyu Ni
TGTianyuan Gu
Tianyuan Gu
PSPanyang Shen
Panyang Shen
ZMZixuan Mei
Zixuan Mei
YWYizheng Wu
Yizheng Wu
SSShuying Shen
Shuying Shen
Maintaining chondrocyte homeostasis is crucial for the effective treatment of osteoarthritis. Chondrocytes reside in a hypoxic environment under physiological conditions. This study, conducted exclusively in male mice, examines the association between epigenetics and chondrocyte homeostasis and observes significant alterations in histone acetylation in chondrocytes under hypoxic conditions. We identify a key enhancer element that regulates the long non-coding RNA CADM1-AS1, which is essential for cartilage homeostasis. This work elucidates a mechanism of epigenetic modulation that contributes to chondrocyte dysfunction in osteoarthritis. Further mechanistic investigations show that CADM1-AS1 recruits histone deacetylase complexes to suppress the transcriptional activation of NOS2, thereby affecting amino acid metabolism in chondrocytes. Conditional knockout of CADM1-AS1 in chondrocytes accelerates osteoarthritis development in mice. Using a hybrid exosome delivery system, we successfully modulate the expression of CADM1-AS1 and effectively reduce cartilage damage. Collectively, these findings reveal the importance of epigenetic regulation via CADM1-AS1-mediated histone deacetylation in the pathogenesis of osteoarthritis. Thus, CADM1-AS1 represents a potential therapeutic target for reducing cartilage damage in osteoarthritis and improving disease management.